AGC Biologics Competitors and Similar CompaniesClear all

AGC Biologics's competitors and similar companies include Aldevron, Vetter Pharma, Mankind Pharma and Alembic Pharmaceuticals.

	AGC Biologics AGC Biologics is a company that specializes in the development and manufacturing of biopharmaceuticals.	Aldevron Aldevron is a company that specializes in manufacturing solutions and regulatory support for both viral and non-viral vector therapies.	Vetter Pharma Vetter Pharma-Fertigung is a company that specializes in aseptic filling for the pharmaceutical and biotech industries.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
Founding Date	Founding Date 2018	Founding Date 1998	Founding Date 1950	Founding Date 1995	Founding Date 2010
Type	Type Private	Type Subsidiary	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare bioengineering biotech	Tags Healthcare drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Bothell, US HQ Copenhagen, DK Heidelberg, DE Milan, IT Milan, IT Ichihara, JP Boulder, US see more	Locations Fargo, US HQ Madison, US	Locations Ravensburg, DE HQ Rankweil, AT Shanghai, CN Langenargen, DE Ravensburg, DE Ravensburg, DE Ravensburg, DE see more	Locations New Delhi, IN HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN
Employees	Employees 2,569	Employees 8052% decrease	Employees 6,0858% increase	Employees 16,2532% increase	Employees 14,858
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $300m (Y, 2020)	Revenue (est.) €1b (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €173m (FY, 2023)	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €828.9m (FY, 2023)	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)
Net income	Net income N/A	Net income N/A	Net income €74.9m (FY, 2023)	Net income N/A	Net income ₹6.7b (FY, 2026)